利妥昔单抗治疗非副肿瘤性自身免疫性视网膜病变。 - Suppr

Suppr

超能文献

Rituximab treatment for nonparaneoplastic autoimmune retinopathy.

作者信息

Fox Austin, Jeffrey Brett, Hasni Sarfaraz, Nussenblatt Robert, Sen H Nida

机构信息

National Eye Institute, Bethesda, Md.

National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Md.

出版信息

Can J Ophthalmol. 2015 Dec;50(6):e101-4. doi: 10.1016/j.jcjo.2015.08.009.

DOI:10.1016/j.jcjo.2015.08.009

PMID:26651312

Abstract

摘要

相似文献

Rituximab treatment for nonparaneoplastic autoimmune retinopathy.

Can J Ophthalmol. 2015 Dec;50(6):e101-4. doi: 10.1016/j.jcjo.2015.08.009.

Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.

Ocul Immunol Inflamm. 2020 Aug 17;28(6):958-965. doi: 10.1080/09273948.2019.1636094. Epub 2019 Aug 16.

Paraneoplastic optic neuropathy and retinopathy associated with colon adenocarcinoma.

Can J Ophthalmol. 2013 Oct;48(5):e116-20. doi: 10.1016/j.jcjo.2013.03.009.

Outcomes in Autoimmune Retinopathy Patients Treated With Rituximab.

Am J Ophthalmol. 2017 Aug;180:124-132. doi: 10.1016/j.ajo.2017.04.019. Epub 2017 May 5.

Slowly progressive cancer-associated retinopathy.

Arch Ophthalmol. 2007 Oct;125(10):1431-3. doi: 10.1001/archopht.125.10.1431.

Remission of nonparaneoplastic autoimmune retinopathy after minimal steroid treatment.

Retin Cases Brief Rep. 2015 Spring;9(2):173-6. doi: 10.1097/ICB.0000000000000131.

Slowly progressive non-neoplastic autoimmune-like retinopathy.

Graefes Arch Clin Exp Ophthalmol. 2011 Jan;249(1):155-8. doi: 10.1007/s00417-010-1436-4. Epub 2010 Jul 13.

Carcinoma-associated retinopathy in a young teenager with immature teratoma of the ovary.

J AAPOS. 2014 Aug;18(4):396-8. doi: 10.1016/j.jaapos.2014.03.007.

Multifocal visual evoked potential, multifocal electroretinography, and optical coherence tomography in the diagnosis of subclinical loss of vision.

Ophthalmol Clin North Am. 2004 Mar;17(1):89-105. doi: 10.1016/S0896-1549(03)00104-4.

NONPARANEOPLASTIC AUTOIMMUNE RETINOPATHY VERSUS PERICENTRAL RETINAL DEGENERATION PHENOTYPE: WHICH CAME FIRST? A CASE REPORT.

Retin Cases Brief Rep. 2023 Jul 1;17(4):384-388. doi: 10.1097/ICB.0000000000001199.

引用本文的文献

Diagnosis and treatment of autoimmune retinopathy: review of current approaches.

Int Ophthalmol. 2025 Aug 18;45(1):341. doi: 10.1007/s10792-025-03696-y.

Clinical Outcomes of Therapeutic Interventions for Autoimmune Retinopathy: A Meta-analysis and Systematic Review.

Ophthalmol Sci. 2024 Sep 12;5(1):100622. doi: 10.1016/j.xops.2024.100622. eCollection 2025 Jan-Feb.

Rituximab in the Treatment of Non-Infectious Uveitis: A Review.

J Inflamm Res. 2024 Sep 29;17:6765-6780. doi: 10.2147/JIR.S477708. eCollection 2024.

Structural and Functional Changes in Non-Paraneoplastic Autoimmune Retinopathy.

Diagnostics (Basel). 2023 Nov 3;13(21):3376. doi: 10.3390/diagnostics13213376.

Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy.

J Ophthalmic Vis Res. 2022 Nov 29;17(4):515-528. doi: 10.18502/jovr.v17i4.12304. eCollection 2022 Oct-Dec.

Rituximab for non-infectious Uveitis and Scleritis.

J Ophthalmic Inflamm Infect. 2021 Aug 16;11(1):23. doi: 10.1186/s12348-021-00252-4.

Rituximab for autoimmune retinopathy: Results of a Phase I/II clinical trial.

Taiwan J Ophthalmol. 2020 Jul 27;11(1):64-70. doi: 10.4103/tjo.tjo_32_20. eCollection 2021 Jan-Mar.

An update on autoimmune retinopathy.

Indian J Ophthalmol. 2020 Sep;68(9):1829-1837. doi: 10.4103/ijo.IJO_786_20.

Non-paraneoplastic related retinopathy: clinical challenges and review.

Ophthalmic Genet. 2019 Aug;40(4):293-297. doi: 10.1080/13816810.2019.1650072. Epub 2019 Aug 8.

Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G>A mutation in ceroid lipofuscinosis neuronal 3 (CLN3).

Doc Ophthalmol. 2019 Feb;138(1):55-70. doi: 10.1007/s10633-018-9665-7. Epub 2018 Nov 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Rituximab treatment for nonparaneoplastic autoimmune retinopathy.

Can J Ophthalmol. 2015 Dec;50(6):e101-4. doi: 10.1016/j.jcjo.2015.08.009.

Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.

Ocul Immunol Inflamm. 2020 Aug 17;28(6):958-965. doi: 10.1080/09273948.2019.1636094. Epub 2019 Aug 16.

Paraneoplastic optic neuropathy and retinopathy associated with colon adenocarcinoma.

Can J Ophthalmol. 2013 Oct;48(5):e116-20. doi: 10.1016/j.jcjo.2013.03.009.

Outcomes in Autoimmune Retinopathy Patients Treated With Rituximab.

Am J Ophthalmol. 2017 Aug;180:124-132. doi: 10.1016/j.ajo.2017.04.019. Epub 2017 May 5.

Slowly progressive cancer-associated retinopathy.

Arch Ophthalmol. 2007 Oct;125(10):1431-3. doi: 10.1001/archopht.125.10.1431.

Remission of nonparaneoplastic autoimmune retinopathy after minimal steroid treatment.

Retin Cases Brief Rep. 2015 Spring;9(2):173-6. doi: 10.1097/ICB.0000000000000131.

Slowly progressive non-neoplastic autoimmune-like retinopathy.

Graefes Arch Clin Exp Ophthalmol. 2011 Jan;249(1):155-8. doi: 10.1007/s00417-010-1436-4. Epub 2010 Jul 13.

Carcinoma-associated retinopathy in a young teenager with immature teratoma of the ovary.

J AAPOS. 2014 Aug;18(4):396-8. doi: 10.1016/j.jaapos.2014.03.007.

Multifocal visual evoked potential, multifocal electroretinography, and optical coherence tomography in the diagnosis of subclinical loss of vision.

Ophthalmol Clin North Am. 2004 Mar;17(1):89-105. doi: 10.1016/S0896-1549(03)00104-4.

NONPARANEOPLASTIC AUTOIMMUNE RETINOPATHY VERSUS PERICENTRAL RETINAL DEGENERATION PHENOTYPE: WHICH CAME FIRST? A CASE REPORT.

Retin Cases Brief Rep. 2023 Jul 1;17(4):384-388. doi: 10.1097/ICB.0000000000001199.

引用本文的文献

Diagnosis and treatment of autoimmune retinopathy: review of current approaches.

Int Ophthalmol. 2025 Aug 18;45(1):341. doi: 10.1007/s10792-025-03696-y.

Clinical Outcomes of Therapeutic Interventions for Autoimmune Retinopathy: A Meta-analysis and Systematic Review.

Ophthalmol Sci. 2024 Sep 12;5(1):100622. doi: 10.1016/j.xops.2024.100622. eCollection 2025 Jan-Feb.

Rituximab in the Treatment of Non-Infectious Uveitis: A Review.

J Inflamm Res. 2024 Sep 29;17:6765-6780. doi: 10.2147/JIR.S477708. eCollection 2024.

Structural and Functional Changes in Non-Paraneoplastic Autoimmune Retinopathy.

Diagnostics (Basel). 2023 Nov 3;13(21):3376. doi: 10.3390/diagnostics13213376.

Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy.

J Ophthalmic Vis Res. 2022 Nov 29;17(4):515-528. doi: 10.18502/jovr.v17i4.12304. eCollection 2022 Oct-Dec.

Rituximab for non-infectious Uveitis and Scleritis.

J Ophthalmic Inflamm Infect. 2021 Aug 16;11(1):23. doi: 10.1186/s12348-021-00252-4.

Rituximab for autoimmune retinopathy: Results of a Phase I/II clinical trial.

Taiwan J Ophthalmol. 2020 Jul 27;11(1):64-70. doi: 10.4103/tjo.tjo_32_20. eCollection 2021 Jan-Mar.

An update on autoimmune retinopathy.

Indian J Ophthalmol. 2020 Sep;68(9):1829-1837. doi: 10.4103/ijo.IJO_786_20.

Non-paraneoplastic related retinopathy: clinical challenges and review.

Ophthalmic Genet. 2019 Aug;40(4):293-297. doi: 10.1080/13816810.2019.1650072. Epub 2019 Aug 8.

Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G>A mutation in ceroid lipofuscinosis neuronal 3 (CLN3).

Doc Ophthalmol. 2019 Feb;138(1):55-70. doi: 10.1007/s10633-018-9665-7. Epub 2018 Nov 16.